US equities |
SPCX $162.69 ▲+10.08% MU $913.25 ▲+1.92% TSLA $386.38 ▲+3.39% NVDA $220.50 ▲+1.86% SNDK $1,384.01 ▲+1.36% META $710.61 ▲+2.36% GOOGL $332.95 ▼-2.15% AAPL $343.71 ▲+1.24%
FinancialContent

Articles published by Bionyra Pharma

News headline image
Bionyra Pharma Announces Positive Interim Phase 1 Results for BYN-002, a Long-Acting Anti-TL1A Antibody
From Bionyra Pharma
Via Business Wire
News headline image
Bionyra Pharma Announces First Healthy Volunteers Dosed in Phase 1 Study of BYN-001, a Long-Acting IL-25 Antibody for Atopic Dermatitis
From Bionyra Pharma
Via Business Wire
News headline image
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases
From Bionyra Pharma
Via Business Wire